Is Viropro Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Viropro Inc (VPRO) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Viropro Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Viropro Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Viropro Inc?

Muslim investors may consider investing in Viropro Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Viropro Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Viropro Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Viropro Inc updated?

The Shariah compliance status of Viropro Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Viropro Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Viropro Inc?

You can check the latest Shariah compliance status of Viropro Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Viropro Inc. Stock Analysis VPRO

United States N/A Nano Cap

Viropro, Inc. engages in the development, manufacture and sale of biopharmaceutical products. The company is headquartered in Irvine, California and currently employs 34 full-time employees. The company went IPO on 2001-06-21. The firm conducts operations primarily through its subsidiary, Alpha Biologics Sdn Bhd (Alpha) located in Penang, Malaysia. The firm intends to offer solution to the biopharma industry from drug concept through to product manufacturing. The Alpha facility consists of approximately 50,000 square feet of research and production space. The Alpha facility is designed to support the scale-up and manufacture of monoclonal antibodies.

Key Statistics of Viropro Inc (VPRO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

300.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

1270.20

Avg. Volume

135.36K

Dividend Yield

Financial Metrics & Statements of Viropro Inc (VPRO)

FAQ's for Viropro Inc (VPRO)

According to Musaffa’s Shariah screening methodology, Viropro Inc (VPRO) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.